Media & Events
Contact
Investors
About
+
-
Get To Know Us
Leadership Team
Board Of Directors
Commercial Team
A Welcoming CDMO: It's The Texas In Us
Videos
Careers
Clinical Biomanufacturing
+
-
Clinical Biomanufacturing
+
-
cGMP Mammalian Cell Culture
cGMP Microbial Fermentation
Process Development
+
-
Mammalian Cell Culture Development
Cell Therapy Development
Microbial Fermentation Development
Downstream Process Development
Formulation Development
Commercial Manufacturing
Bioanalytical Services
+
-
Methods Development
Technologies
Pre-Clinical & Product Development Services
+
-
Toxicokinetic Studies (TK)
Comprehensive Immune Profiling
Cell-Based Potency Assays
CMC Analytical Support Services
+
-
Release Testing
Stability Testing
Bioassays
Media & Events
Contact
Investors
Media & Events
Get To Know Us
All Media
News
Events
Articles
Blogs
Resources
events
World Vaccine Congress 2024
April 1-4, 2024
Washington,
DC, USA
Meet with Scorpius at the World Vaccine Congress in Washington.
BOOK A MEETING
NightHawk Biosciences Completes Name Change to Scorpius Holdings
NightHawk Biosciences announced its name change to Scorpius Holdings, Inc., to better reflect the company’s successful shift into a pure-play, large molecule biomanufacturing CDMO.
February 6, 2024
articles
Tech Transfer Best Practices
Avoid Clinical Manufacturing Pitfalls With These 4 Tech Transfer Best Practices - New Webinar Now On Demand!
March 12, 2024
Webinar
Biologics CDMO: Four Critical Aspects of Clinical Development, Manufacturing, and Analysis
Watch Now
DOWNLOAD
blogs
Bench To The Clinic: Biomanufacturing 101 for University Researchers
Discover how Scorpius BioManufacturing can assist University researchers in navigating translational biomanufacturing.
March 7, 2024
events
Texas Life Sciences Summit 2024
April 2, 2024
Austin,
TX, USA
Meet with Scorpius at the Texas Life Sciences Summit in Austin.
BOOK A MEETING
events
Generis American Biomanufacturing Summit 2024
April 10-11, 2024
San Francisco,
CA, USA
Meet with Scorpius at the Generis American Biomanufacturing Summit in San Francisco.
BOOK A MEETING
events
Biofest Invest 2024
April 17, 2024
San Antonio,
TX, USA
Meet with Scorpius at Biofest Invest in San Antonio.
BOOK A MEETING
events
BIO International Convention 2024
June 3-6, 2024
San Diego,
CA, USA
Meet with Scorpius at BIO 2024 in San Diego.
BOOK A MEETING
events
BioProcessing Summit 2024
August 19-22, 2024
Boston,
MA, USA
Meet with Scorpius at the BioProcessing Summit in Boston.
BOOK A MEETING
events
hubXchange San Francisco 2024
September 23-24, 2024
San Francisco,
CA, USA
Meet with Scorpius at the Advanced Therapies & Antibody Therapeutics Xchange in San Francisco.
BOOK A MEETING
events
CPhI Milan
October 8-10, 2024
Milan,
Italy
Meet with Scorpius at CPHI to discuss how we can meet your biomanufacturing and bioanalytical needs.
BOOK A MEETING
articles
Scorpius' Ania Szymanska Featured in Pharmaceutical Technology’s February 2024 E-book
Scorpius BioManufacturing's Site Head of Quality, Ania Szymanska shares her expertise on how to evaluate a CDMO’s commitment to quality in Pharmaceutical Technology’s February 2024 E-book.
March 4, 2024
blogs
How to Create a Successful Business and Technical Relationship with a CDMO
Scorpius BioManufacturing shares customer input on what makes for a successful business and technical relationship between sponsors and biologics CDMO.
February 6, 2024
news
Scorpius BioManufacturing Announces Joe Payne as President and Chief Operating Officer
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), promoted Joe Payne to President and COO.
February 1, 2024
articles
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
Why Fina Biosolutions Partnered With Scorpius BioManufacturing for cGMP Production of EcoCRM® (CRM197)
December 8, 2023
blogs
How to Select the Right Biologics CDMO Partner
The article discusses essential & strategic considerations throughout the biologics CDMO selection process, including weighing options to make the best decisions.
December 1, 2023
blogs
Evaluating Biologics CDMOs: Tips for Crafting an RFP
Suggestions for designing an effective RFP for a biologics CDMO selection process, including how to approach RFP design & the information it should gather.
November 14, 2023
articles
From frustration to innovation: a CDMO’s mission to empower emerging biotechs
Capacity, capacity, capacity. This seems to be all the industry talks about. A global pandemic magnified the need for more biologics manufacturing capacity. Capacity, however, isn’t the whole story.
October 20, 2023
blogs
5 New Questions to Ask Before Signing with a Biologics CDMO
This article discusses the current value biologics CDMOs bring to their innovator customers and new questions for selecting a CDMO partner.
October 17, 2023
blogs
Top 6 Questions to Ask When Evaluating a Biologics CDMO
When selecting a biologics CDMO partner, an innovator must ask the right questions to make the best decision. This article shares six top considerations.
September 12, 2023
blogs
3 Trends Innovative Biologics CDMOs Are Embracing
Deep Dive: Top 3 Biologics Trends Shaping the Future with Scorpius.
July 31, 2023
articles
Does Your Biologics CDMO Truly Have a Culture of Quality?
Joe Payne, Scorpius' President & COO, shares what 20+ years in pharma has taught him about creating a culture of quality.
July 27, 2023
news
Fina Biosolutions Selects Scorpius BioManufacturing for Production of cGMP CRM₁₉₇
Fina Biosolutions has selected Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), for the production of an E.coli-expressed CRM
197
conjugate ...
July 27, 2023
blogs
Scorpius Highlighted In Drug Development & Delivery's Annual Report
Scorpius highlighted in Drug Development & Delivery's annual CDMO report
July 21, 2023
news
Scorpius Expands Leadership Team With New VP, Manufacturing Operations
Scorpius BioManufacturing, a biologics contract development and manufacturing organization (CDMO), expanded its leadership to include Matthew R. LeClair.
July 7, 2023
news
Scorpius’ Steve Lavezoli Featured In Contract Pharma
3 key contract development and manufacturing organization (CDMO) trends shaping the biologics in 2023
July 6, 2023
blogs
Emerging Horizons: The Evolving Biologics Trends
Unveiling the Future: Biologics Development & Key Industry Shifts with Scorpius.
June 23, 2023
blogs
How a Biologics CDMO Adds Value to mAbs Development & Manufacturing Programs
A look at a CDMO’s value throughout a monoclonal antibody (mAb) therapeutic's lifecycle
June 16, 2023
news
Scorpius BioManufacturing Announces the Appointment of Joe Payne as VP, Quality & Regulatory Affairs
Scorpius BioManufacturing Announces the Appointment of Joe Payne as VP, Quality & Regulatory Affairs
May 11, 2023
articles
Biologics Outsourcing: Decision Drivers and Key Considerations
A recent survey of 100 decision makers at innovative biologics companies revealed 57% of respondents believe their companies’ outsourcing activities will increase over the next two years, while a furt...
April 17, 2023
news
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
Scorpius BioManufacturing Announces the Appointment of Gary Welch as Interim President
March 21, 2023
articles
An Experienced CDMO Can Be a Differentiator in the Rapidly Growing Biologics Market
By providing end-to-end services — including secure supply chains — CRO/CDMOs, like Scorpius BioManufacturing can help biologics developers meet accelerated timelines and establish a real competitive ...
January 31, 2023
news
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
Scorpion Biological Services Becomes Scorpius BioManufacturing to Reflect Expansion
December 20, 2022
news
Scorpius BioManufacturing Celebrates Grand Opening of its San Antonio Facility
Scorpius BioManufacturing Celebrates Grand Opening of its San Antonio Facility
October 25, 2022
news
Scorpius BioManufacturing Appoints Stephan Kutzer, Ph.D. as Interim Chief Executive Officer (CEO)
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpius BioManufacturing announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive Officer.
June 14, 2022
articles
The Bioanalytical Development Journey
Biopharma companies outsource pharmaceutical development and manufacturing from discovery, bioanalytical testing, qualification to validation.
May 18, 2022
articles
Evaluating Single-Use Technologies for Biomanufacturing
Single-use technologies (SUTs) are ideal for multiproduct facilities producing smaller volumes of materials.
November 22, 2021
articles
ABC: Analytics for Biomanufacturing and Clinical Trials of Biomanufactured Products
Samir Lakhashe, Director, Bioanalysis, discusses assay categorization, the company's growing toolbox, predictions for the future, and what scientists who want to join the growing team should know, wit...
October 15, 2021